Sector consensus Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.93 USD | +2.64% |
|
-3.41% | +11.08% |
| 07-20 | Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 59.31 | +21.22% | 16 | ||||||
| 1,029.81 | +14.63% | 15 | ||||||
| 150.47 | +20.71% | 18 | ||||||
| 106.88 | +33.41% | 20 | ||||||
| 196.18 | +87.32% | 22 | ||||||
| 40.64 | +21.74% | 23 | ||||||
| 2,392.08 | +25.37% | 15 | ||||||
| 567.11 | +10.44% | 17 | ||||||
| 1,073.31 | -10.18% | 7 | ||||||
| 52.07 | -6.71% | 15 | ||||||
| 680 | +23.36% | 15 | ||||||
| 104.27 | +21.91% | 11 | ||||||
| 146.3 | +71.83% | 20 | ||||||
| 107.8 | +33.71% | 20 | ||||||
| 21.07 | +114.49% | 13 | ||||||
| 82.5 | -1.61% | 10 | ||||||
| 103.93 | +3.89% | 15 | ||||||
| 100.42 | +35.78% | 15 | ||||||
| - | - | - | - | |||||
| 109 | +96.4% | 9 | ||||||
| Average | 374.9 | +32.51% | 16 | ||||||
| Weighted average by Cap. | 471.38 | +28.73% | 16 |
- Stock Market
- Stocks
- SRRK Stock
- Sector Scholar Rock Holding Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
